Fatmahan Atalar

718 total citations
23 papers, 580 citations indexed

About

Fatmahan Atalar is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Fatmahan Atalar has authored 23 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Cardiology and Cardiovascular Medicine and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Fatmahan Atalar's work include Cardiovascular Disease and Adiposity (6 papers), Ion channel regulation and function (4 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (3 papers). Fatmahan Atalar is often cited by papers focused on Cardiovascular Disease and Adiposity (6 papers), Ion channel regulation and function (4 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (3 papers). Fatmahan Atalar collaborates with scholars based in Türkiye, Cyprus and Tanzania. Fatmahan Atalar's co-authors include J.‐C. Voegel, Philippe Lavall�e, Jean‐Pierre Jessel, Uğur Özbek, Jérôme Mutterer, Gero Decher, Pierre Schaaf, Ayşe Demirkan, Belhhan Akpınar and Burçak Vural and has published in prestigious journals such as Advanced Materials, Gene and Pflügers Archiv - European Journal of Physiology.

In The Last Decade

Fatmahan Atalar

22 papers receiving 571 citations

Peers

Fatmahan Atalar
Samuel Y. Boateng United Kingdom
James A. Thorn United Kingdom
Zhi Wei Lim Singapore
Jürgen Hannig United States
Ryan M. Jamiolkowski United States
Carolyn L. Bayer United States
Matthew R. Wolff United States
Samuel Y. Boateng United Kingdom
Fatmahan Atalar
Citations per year, relative to Fatmahan Atalar Fatmahan Atalar (= 1×) peers Samuel Y. Boateng

Countries citing papers authored by Fatmahan Atalar

Since Specialization
Citations

This map shows the geographic impact of Fatmahan Atalar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatmahan Atalar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatmahan Atalar more than expected).

Fields of papers citing papers by Fatmahan Atalar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fatmahan Atalar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatmahan Atalar. The network helps show where Fatmahan Atalar may publish in the future.

Co-authorship network of co-authors of Fatmahan Atalar

This figure shows the co-authorship network connecting the top 25 collaborators of Fatmahan Atalar. A scholar is included among the top collaborators of Fatmahan Atalar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fatmahan Atalar. Fatmahan Atalar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Atalar, Fatmahan, et al.. (2025). Alpha-mangostin and nab-paclitaxel in breast cancer cell models: improvedantitumor efficacy through combination therapy. Cellular and Molecular Biology. 71(1). 52–59. 1 indexed citations
2.
Öncü, Fatih, et al.. (2025). Thyroid Hormone Dynamics and DIO2 Variants in Schizophrenia: Exploring Genetic Links to Neuroendocrine Imbalance. Journal of Cellular and Molecular Medicine. 29(13). e70694–e70694. 1 indexed citations
6.
Atalar, Fatmahan, et al.. (2015). PAI-1 and TNF-α profiles of adipose tissue in obese cardiovascular disease patients.. PubMed. 8(12). 15919–25. 25 indexed citations
7.
Atalar, Fatmahan, et al.. (2015). Therapeutic potential of cyclooxygenase-3 inhibitors in the management of glioblastoma. Journal of Neuro-Oncology. 126(2). 271–278. 28 indexed citations
8.
Anak, Sema, et al.. (2014). herg1b Expression as a Potential Specific Marker in Pediatric Acute Myeloid Leukemia Patients with HERG 897K/K Genotype. Pediatric Hematology and Oncology. 32(3). 182–192. 10 indexed citations
9.
Tuğcu, Volkan, Abdülmuttalip Şimşek, Fatmahan Atalar, et al.. (2013). OPN gene polymorphism (Ala250) and lower serum OPN levels are associated with urolithiasis. Renal Failure. 35(6). 825–829. 5 indexed citations
11.
Yalçınkaya, Nazlı, Soykan Arıkan, Elif Özkök, et al.. (2013). Identification of a Novel BRCA2 and CHEK2 A-C-G-C Haplotype in Turkish Patients Affected with Breast Cancer. Asian Pacific Journal of Cancer Prevention. 14(5). 3229–3235. 7 indexed citations
12.
Atalar, Fatmahan, Burçak Vural, Ayşe Demirkan, et al.. (2012). 11β-hydroxysteroid dehydrogenase type 1 gene expression is increased in ascending aorta tissue of metabolic syndrome patients with coronary artery disease. Genetics and Molecular Research. 11(3). 3122–3132. 8 indexed citations
13.
Atalar, Fatmahan, Barış Çaynak, Gamze Tanrıverdi, et al.. (2012). The role of mediastinal adipose tissue 11β-hydroxysteroid d ehydrogenase type 1 and glucocorticoid expression in the development of coronary atherosclerosis in obese patients with ischemic heart disease. Cardiovascular Diabetology. 11(1). 115–115. 13 indexed citations
14.
Atalar, Fatmahan, Barış Çaynak, Gamze Tanrıverdi, et al.. (2012). Mediastinal adipose tissue expresses a pathogenic profile of 11 β-hydroxysteroid dehydrogenase Type 1, glucocorticoid receptor, and CD68 in patients with coronary artery disease. Cardiovascular Pathology. 22(3). 183–188. 10 indexed citations
15.
Baş, Firdevs, et al.. (2012). No Effect of the IGF-1 Gene rs35767 and rs17032362 Polymorphisms in the Etiology of Idiopathic Short Stature. Experimental and Clinical Endocrinology & Diabetes. 120(7). 395–400. 1 indexed citations
16.
Atalar, Fatmahan, et al.. (2010). Two four-marker haplotypes on 7q36.1 region indicate that the potassium channel gene HERG1 (KCNH2, Kv11.1) is related to schizophrenia: a case control study. Behavioral and Brain Functions. 6(1). 27–27. 32 indexed citations
17.
Baş, Firdevs, Hülya Kayserili, Feyza Darendelıler, et al.. (2009). CYP21A2 Gene Mutations in Congenital Adrenal Hyperplasia: Genotype-phenotype correlation in Turkish children. Journal of Clinical Research in Pediatric Endocrinology. 1(3). 116–128. 35 indexed citations
18.
Chtcheglova, Lilia A., Fatmahan Atalar, Uğur Özbek, et al.. (2008). Localization of the ergtoxin-1 receptors on the voltage sensing domain of hERG K+ channel by AFM recognition imaging. Pflügers Archiv - European Journal of Physiology. 456(1). 247–254. 38 indexed citations
19.
Vural, Burçak, Fatmahan Atalar, Ayşe Demirkan, et al.. (2008). Presence of fatty-acid-binding protein 4 expression in human epicardial adipose tissue in metabolic syndrome. Cardiovascular Pathology. 17(6). 392–398. 74 indexed citations
20.
Jessel, Jean‐Pierre, Fatmahan Atalar, Philippe Lavall�e, et al.. (2003). Bioactive Coatings Based on a Polyelectrolyte Multilayer Architecture Functionalized by Embedded Proteins. Advanced Materials. 15(9). 692–695. 206 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026